Middleton & Co. Inc. MA Has $14.27 Million Holdings in Danaher Corporation $DHR

Middleton & Co. Inc. MA cut its position in shares of Danaher Corporation (NYSE:DHR) by 3.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,223 shares of the conglomerate’s stock after selling 2,450 shares during the quarter. Danaher comprises about 1.6% of Middleton & Co. Inc. MA’s holdings, making the stock its 17th largest position. Middleton & Co. Inc. MA’s holdings in Danaher were worth $14,267,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Red Tortoise LLC grew its holdings in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Costello Asset Management INC acquired a new stake in Danaher in the first quarter worth $41,000. Ramirez Asset Management Inc. acquired a new stake in Danaher in the second quarter worth $40,000. Mowery & Schoenfeld Wealth Management LLC grew its holdings in Danaher by 53.8% in the first quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock worth $42,000 after purchasing an additional 71 shares during the period. Finally, Iron Horse Wealth Management LLC acquired a new stake in Danaher in the first quarter worth $50,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock opened at $212.34 on Thursday. The firm has a market cap of $149.99 billion, a price-to-earnings ratio of 43.78, a P/E/G ratio of 3.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The firm’s 50-day simple moving average is $203.83 and its two-hundred day simple moving average is $200.07.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the firm posted $1.71 earnings per share. The company’s quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were given a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is 26.39%.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the business’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Sunday. Cowen reiterated a “buy” rating on shares of Danaher in a report on Wednesday, October 22nd. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a report on Thursday, October 23rd. Finally, Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.